Point72 Asset Management’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-207,100	Closed	-$1.36M	–	1545
2024 Q3	$1.36M	Sell	207,100 -396,481	-66%	-$2.6M	﹤0.01%	796
2024 Q2	$4.38M	Buy	603,581 +165,181	+38%	+$1.2M	0.01%	650
2024 Q1	$3.33M	Sell	438,400 -12,000	-3%	-$91.1K	0.01%	792
2023 Q4	$2.05M	Sell	450,400 -4,600	-1%	-$20.9K	0.01%	852
2023 Q3	$1.8M	Sell	455,000 -384,000	-46%	-$1.52M	0.01%	839
2023 Q2	$2.63M	Buy	839,000 +384,000	+84%	+$1.2M	0.01%	774
2023 Q1	$2.06M	Sell	455,000 -20,000	-4%	-$90.6K	0.01%	797
2022 Q4	$1.96M	Hold	475,000	–	–	0.01%	761
2022 Q3	$1.52M	Buy	+475,000	New	+$1.52M	0.01%	800
2022 Q1	–	Sell	-196,896	Closed	-$2.13M	–	1188
2021 Q4	$2.13M	Hold	196,896	–	–	0.01%	763
2021 Q3	$2.27M	Buy	196,896 +97,736	+99%	+$1.13M	0.01%	718
2021 Q2	$974K	Buy	99,160 +81,900	+475%	+$804K	﹤0.01%	761
2021 Q1	$252K	Hold	17,260	–	–	﹤0.01%	828
2020 Q4	$370K	Hold	17,260	–	–	﹤0.01%	808
2020 Q3	$262K	Hold	17,260	–	–	﹤0.01%	796
2020 Q2	$222K	Sell	17,260 -1	-0%	-$13	﹤0.01%	710
2020 Q1	$159K	Hold	17,261	–	–	﹤0.01%	691
2019 Q4	$230K	Buy	+17,261	New	+$230K	﹤0.01%	794
2019 Q1	–	Sell	-43,678	Closed	-$2.59M	–	1019
2018 Q4	$2.59M	Buy	43,678 +12,887	+42%	+$765K	0.01%	590
2018 Q3	$4.32M	Sell	30,791 -10,042	-25%	-$1.41M	0.02%	508
2018 Q2	$5.01M	Buy	+40,833	New	+$5.01M	0.02%	485
2015 Q2	–	Sell	-217	Closed	-$103K	–	738
2015 Q1	$103K	Buy	+217	New	+$103K	﹤0.01%	616